Insider Trading March 23, 2026

GAM Vice President Acquires Small Stake in Company Preferred Shares

Eugene S. Stark buys 11 shares of General American Investors 5.95% preferred stock; company common yields 10.83%

By Derek Hwang GAM
GAM Vice President Acquires Small Stake in Company Preferred Shares
GAM

Eugene S. Stark, General American Investors Co Inc's vice president overseeing administration and financial controls, purchased 11 shares of the firm's 5.95% preferred stock on March 20, 2026, spending $274. The filing shows Stark already holds larger direct and indirect positions in the preferred series and common shares. The investment company’s equity pays a 10.83% yield and has a 54-year record of consecutive dividend payments.

Key Points

  • Eugene S. Stark purchased 11 shares of General American Investors' 5.95% Preferred Stock at $24.95 per share on March 20, 2026, for a total of $274.
  • The Form 4 filing shows Stark holds substantial additional preferred and common shares both directly and indirectly, including 27,011 preferred shares directly and 10,000 common shares directly.
  • GAM's common stock traded at $59.82 with a dividend yield of 10.83%, and the company has paid dividends for 54 consecutive years, per InvestingPro.

Eugene S. Stark, who serves as VP Administration/CCO/PFO at General American Investors Co Inc (NYSE:GAM), reported a recent purchase of 11 shares of the company's 5.95% Preferred Stock at a per-share price of $24.95. The total cost of the transaction was $274, according to a Form 4 filing with the Securities and Exchange Commission covering activity on March 20, 2026.

The filing documents Stark's wider holdings in the issuer. After the March 20 transaction, Stark directly holds 27,011 shares of the 5.95% Preferred Stock. The filing also lists indirect holdings of 12,000 preferred shares in an IRA account, 4,000 preferred shares held by a spouse, and 101,303 preferred shares held by the Issuer's Employees' Thrift Plan Trust. In addition to preferred-stock positions, the filing shows Stark directly owns 10,000 common shares of GAM.

At the time of the report, GAM's common stock was trading at $59.82 and carried a dividend yield of 10.83%. The company is noted for a long-standing record of dividend payments, having made distributions for 54 consecutive years, as reported by InvestingPro.


Transaction details

  • Insider: Eugene S. Stark, VP Administration/CCO/PFO
  • Security purchased: 5.95% Preferred Stock
  • Shares acquired: 11
  • Price per share: $24.95
  • Total transaction value: $274
  • Filing date: March 20, 2026 (Form 4)

Reported holdings following the trade

  • Direct ownership of preferred: 27,011 shares
  • Indirect preferred holdings: 12,000 shares (IRA), 4,000 shares (spouse), 101,303 shares (Employees' Thrift Plan Trust)
  • Direct common shares: 10,000

The filing situates the small, recent preferred purchase within a broader ownership profile for Stark. The disclosure also coincides with market data showing GAM's common stock price and stated dividend yield. The note on a 54-year streak of dividend payments is presented as a historical record of distributions, as reported by InvestingPro.

Information in the Form 4 provides a snapshot of the purchase and Stark's holdings but does not include commentary on motive or future company actions. The filing and market figures make clear the size of the most recent transaction relative to Stark's aggregate positions.

Risks

  • The disclosed purchase is small in absolute terms - 11 preferred shares totaling $274 - relative to Stark's larger reported holdings, which may limit the trade's informational significance for investors.
  • The article does not provide forward-looking statements or company guidance about future dividends or capital actions; the 54-year dividend record is historical and does not guarantee future payments.
  • The Form 4 filing documents ownership quantities and the transaction date but does not state motive or strategic intent behind the purchase, leaving the rationale unclear.

More from Insider Trading

Spyre Therapeutics CFO Disposes $370K in Stock, Exercises Options Same Day as Trial Timelines Accelerate Apr 3, 2026 Fold Holdings CEO completes modest stock sale to cover RSU tax obligations Apr 3, 2026 Spyre Therapeutics CEO Executes $739,912 Stock Sale as Trials Accelerate Apr 3, 2026 Spyre Therapeutics CMO Sells Shares, Exercises Options as Trials Accelerate Apr 3, 2026 Fold CFO Sells Small Stake to Meet Tax Withholding as Company Faces Revenue Shortfall Apr 3, 2026